Haemonetics Corporation (HAE) Stock Analysis & Winston Score

Haemonetics makes medical devices that collect, process, and manage blood. Its machines are used in hospitals, blood banks, and plasma donation centers to separate blood into its different parts — like red cells, platelets, and plasma — so each part can be used where it is needed most. The company is one of the leading makers of blood management technology in the world. Haemonetics earns money by selling its machines and then charging ongoing fees for the disposable supplies — like collection sets and filters — that customers must buy to keep using those machines. It operates mainly in North America, Europe, and parts of Asia, with annual revenue around $1.1 billion. Its biggest competitive advantage is that once a hospital or plasma center is set up on its equipment, switching to a competitor is costly and disruptive. The key growth driver is rising global demand for plasma-derived medicines, but the company faces risk from customer concentration, since a small number of large plasma collection companies make up a significant share of its revenue.